Current Study Highlights
Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn's Disease
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn's Disease.
Relationship Between Image-derived Features of Intraoperative ICG Visualization of Periprostatic Vasculature and NVBs during RARP and Functional Outcomes
Relationship Between Image-derived Features of Intraoperative ICG Visualization of Periprostatic Vasculature and NVBs during RARP and Functional Outcomes
A First-in-human (FIH) Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)
This clinical trial is designed to test whether a single stereotactic intracerebral administration of inhibitory nerve cells into subjects with drug-resistant mesial temporal lobe epilepsy is safe (frequency of adverse events) and effective (seizure frequency).
Looking for a clinical trial that's right for you?
Contact Our Recruitment Team
Thank you for your interest with our team.
One of our specialists will be in contact with you soon.